Related Experiment Video
Updated: Aug 20, 2026

Live Imaging of Dorsal Root Axons after Rhizotomy
Published on: September 1, 2011
The development and implementation of, and first years' experience with, a massive/emergency transfusion protocol
Eric A Gehrie1, Christopher A Tormey1
1Pathology and Laboratory Medicine Service, VA Connecticut Healthcare System, West Haven Veterans Affairs Hospital, 950 Campbell Avenue, West Haven, CT 06516.
Published reports of massive or emergency transfusion protocols (MTP/ETPs) focus primarily on large trauma centers. There is little guidance available in the literature to assist nontrauma, hospital-based blood banks in the development of an MTP/ETP for occasional bleeding emergencies. Here, we describe the design of an MTP/ETP at the Veterans Affairs Connecticut Healthcare System in West Haven. The MTP/ETP consists of a protocolized distribution of red blood cells (RBCs), fresh frozen plasma (FFP) and platelets (PLTs), with cryoprecipitate and recombinant factor VIIa also available. In the first year of operation, the MTP/ETP was activated five times on five separate patients. All of the MTP/ETP patients received RBCs, FFP, and PLTs. Two out of five patients received cryoprecipitate. None of the patients received recombinant factor VIIa. Four of the five patients who underwent MTP/ETP survived at least 21 days following the event. A total of 2 units of FFP and 4 units of RBCs issued as a part of the MTP/ETP were wasted. The development of an MTP/ETP at our Veterans Affairs hospital helped to ensure that patients requiring massive transfusion received RBCs, FFP, and PLTs in a protocolized fashion as part of their resuscitation with relatively little product wastage.
Published reports of massive or emergency transfusion protocols (MTP/ETPs) focus primarily on large trauma centers. There is little guidance available in the literature to assist nontrauma, hospital-based blood banks in the development of an MTP/ETP for occasional bleeding emergencies. Here, we describe the design of an MTP/ETP at the Veterans Affairs Connecticut Healthcare System in West Haven. The MTP/ETP consists of a protocolized distribution of red blood cells (RBCs), fresh frozen plasma (FFP) and platelets (PLTs), with cryoprecipitate and recombinant factor VIIa also available. In the first year of operation, the MTP/ETP was activated five times on five separate patients. All of the MTP/ETP patients received RBCs, FFP, and PLTs. Two out of five patients received cryoprecipitate. None of the patients received recombinant factor VIIa. Four of the five patients who underwent MTP/ETP survived at least 21 days following the event. A total of 2 units of FFP and 4 units of RBCs issued as a part of the MTP/ETP were wasted. The development of an MTP/ETP at our Veterans Affairs hospital helped to ensure that patients requiring massive transfusion received RBCs, FFP, and PLTs in a protocolized fashion as part of their resuscitation with relatively little product wastage.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Continuous Renal Replacement Therapy